Lung cancer, Mesothelioma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Stage IV lung cancer or mesothelioma with pathological confirmation 2. Age 20 or older 3. Lung cancer or mesothelioma in remission (complete remission or partial remission) that is achieved by chemotherapy and maintained without any cancer treatment for 2 years or longer after the last dose of chemotherapy 4. Available tumor tissue before chemotherapy for DNA and protein analysis 5. Available peripheral blood sample for DNA extraction as a non-cancerous reference 6. Written informed consent
Exclusion criteria
Exclusion criteria: 1. Active double cancer (patients with treatment-free and disease-free state for 3 years or longer after a curative treatment are eligible) 2. Unsuitable to enter this study judged by an attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exploratory assessment of somatic alterations in advanced lung cancer related to marked response to chemotherapy and treatment-free long-term remission | — |
Countries
Japan
Contacts
Aichi Medical University School of Medicine Division of Respiratory Medicine and Allergology